Desmarais LLP received recognition in the 2025 LMG Life Sciences rankings in the “General Patent Litigation” and “Hatch-Waxman Patent Litigation (Branded)” categories, and firm partners John Desmarais, Paul Bondor, and Justin Wilcox were honored as “Life Science Stars.”
During the past 12 months, Desmarais LLP’s life sciences patent litigation successes include three consecutive appellate wins before the Federal Circuit that upheld the patents behind $429.5 million in damages earned in the district courts for the biotech company Ravgen and its non-invasive prenatal genetic testing technology. Desmarais LLP secured the $429.5 million in damages at trial with jury verdicts that include $272.5 million (enhanced to $372.5 million) won against Labcorp and $57 million won against Natera.
The annual LMG Life Sciences rankings highlight the industry’s top firms across four practice areas – regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement. The rankings are based on firms’ achievements during the past year, interviews conducted with practitioners in the industry, and feedback gathered from clients.
See the full LMG Life Sciences rankings
Desmarais LLP Named to BTI’s 2026 Most Feared Law Firms in Litigation
Accolades
BTI Consulting Group recognized Desmarais LLP as one of the industry’s “Most Feared Law Firms in Litigation,” selecting the firm as an “Intimidating Opponent” in its 2026 rankings. The annual list...
MORE
